Abstract
Introduction
Th e fi rst report of a giant cell tumor involving tendon sheaths was published by Jaff e et al in 1941. 1 Since then, cases of giant cell tumors of the soft tissues have been described, with and without involvement of the adjacent joints. Th e terms extra-articular pigmented villonodular synovitis and diff use tenosynovial giant cell tumor have been used synonymously to describe these lesions. 2 Rarely have giant cell tumors been described in the head and neck. We report a case of a giant cell tumor that was centered in the masticator space. As far as we know, this is the fi rst reported case of this tumor in this specifi c location.
Case report
A 50-year-old man presented to our offi ce with complaints of otalgia and eustachian tube dysfunction. His medical and social histories were unremarkable. Despite aggressive medical management, his symptoms persisted, and during further investigation, a fi rmness was noted in his left parotid tail. Computed tomography (CT) demonstrated a heterogeneously enhancing, 2.0 × 3.2 × 1.8-cm mass that was centered in the left masticator space. As a result of the mass eff ect, the pterygoid muscles were deviated superiorly and the left mandibular condyle was deviated laterally. Th e tumor was located medial to the styloid process and to the deep lobe of the parotid gland. Erosion of the medial glenoid fossa was seen, but there was no evidence of condyle erosion. Also observed was erosion of the anterior wall of the semicanal of the tensor tympani and the external auditory canal with extension into the hypotympanum. Th e temporal crest of the greater wing of the sphenoid bone was also destroyed. CT-guided biopsy revealed the presence of giant cells.
Th e patient underwent a transcervical left total parotidectomy. Intraoperatively, a brown mass was found to be situated deep to and separate from the deep lobe of the parotid. It was fi xed superiorly and medially in the masticator space by extensive fi brous banding (fi gure 1). Th e resected tumor appeared to be encapsulated. It measured 3.2 × 2.8 × 1.8 cm. Histopathology revealed that it was predominantly made up of plump mononuclear cells that were admixed with multinucleated giant cells, few lymphocytes, focal foamy macrophages, and hemosiderin-laden macrophages. Some of the mononuclear cells contained cytoplasmic granules of hemosiderin pigment (fi gure 2). Also noted were a focal metaplastic bone formation, a few cleft s lined with mononuclear cells, bands of dense collagen, and a very focal hyalinized stroma. No mitotic activity was noted, nor was there any evidence of necrosis or encapsulation Volume 90, Number 11 www.entjournal.com ■ E21
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abnormalities may lead to malignant transformation in rare cases. 5 Th e fi rst cases of extra-articular diff use giant cell tumors arising from the temporomandibular joint were described by Lapayowker et al in 1973. 6 In these cases, the joint was usually preserved, but erosion of the bone next to the joint was noted in the more advanced cases. Gong et al recently reviewed 38 cases of pigmented villonodular synovitis and tenosynovial giant cell tumor involving the temporomandibular joint. 7 Th ey also reported the fi rst case of extra-articular diff use tenosynovial giant cell tumor of the infratemporal fossa.
In most reported cases of giant cell tumor of the head and neck, the tumor was believed on initial examination to be a parotid tumor. 8 In some cases, patients presented with compression of the auditory canal that resulted in hearing loss and/or tinnitus. 6 Th e treatment of diff use tenosynovial giant cell tumors of the lesion. Immunohistochemical staining was positive for CD68 and negative for cytokeratin.
Immediately following surgery, the patient underwent a repeat CT, which revealed the presence of a minimal amount of residual soft tissue along the posterior aspect of the left mandibular condyle. CT also demonstrated bony erosion involving the medial aspect of the left temporomandibular joint, with soft -tissue extension into the bony left eustachian tube. Such fi ndings are regarded as representative of a stable condition. Followup CTs obtained 3 and 6 months postoperatively yielded similar fi ndings. At 24 months, the patient remained disease-free.
Discussion
Th e diff erential diagnosis in this case included a localized tenosynovial giant cell tumor, a diff use extra-articular tenosynovial giant cell tumor, and a soft -tissue giant cell tumor of low malignant potential. Th e tumor was located primarily in the masticator space, and it appeared to involve bone secondarily. Because it did not appear to have arisen from the bone, it was not believed to be a giant cell tumor of bone. Th e heterogeneous population of cells did not support a diagnosis of soft -tissue giant cell tumor of low malignant potential.
Th e World Health Organization describes tenosynovial giant cell tumors as soft -tissue tumors composed of rounded mononuclear and osteoclastic giant cells that are typically located within joints and bursae or along tendon sheaths. 3 Th ey commonly contain xanthoma cells, lymphocytes, and hemosiderin. 3 Tenosynovial giant cell tumors are further classifi ed as localized and diff use:
• Localized tumors grow as encapsulated masses (which was not the case in our patient), and they typically develop in the tendon sheaths of the hands and feet. 3 Th ey are believed to arise as the result of a translocation between chromosomes 1 and 2. 4 Dal Cin et al noted that the chromosome changes seemed to cluster in the regions of 1p11 and 16q24. 4 • Diff use tumors typically grow as infi ltrative masses, and they usually arise from the bursae or joint spaces near large weight-bearing joints. 3 Diff use tenosynovial giant cell tumors have been further subclassifi ed as intra-articular and extra-articular.
Diff use tumors are associated with higher recurrence rates than are localized tumors. Extra-articular tumors are associated with recurrence rates as high as 40 to 50%. 2 Aneuploid DNA patterns and chromosomal is primarily surgical excision alone. Somerhausen and Fletcher reported a local recurrence rate of 33% for extraarticular diff use giant cell tumors that were excised; most of these recurrences were seen in patients with positive excision margins. 9 Because of the high recurrence rates, close follow-up is recommended. 2 Radiotherapy as an adjuvant to wide surgical excision has been investigated for diff use giant cell tumors. O'Sullivan et al looked into external-beam radiation therapy in moderate doses (35 Gy in 15 fractions) as an adjunct to surgery for intra-articular giant cell tumors and for tumors with extensive extra-articular involvement. 10 To the best of our knowledge, there has not been enough investigation to support its use in diff use extra-articular tenosynovial giant cell tumors involving the area adjacent to the temporomandibular joint.
